Jia Yao

An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs)

Amy M. Avila, Ilona Bebenek, Jessica A. Bonzo et al. · Regulatory Toxicology and Pharmacology · 2020 · 176 citations

Fda/cder Perspective, Preclinical Drug Evaluation, Pharmacology +8

Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria

Chao Zhong, Ningyi Zhu, Yuewen Zhu et al. · European Journal of Pharmaceutical Sciences · 2019 · 119 citations

Antibiotics, Fatty Acids, Medicine +10

Species and release characteristics of VOCs in furniture coating process

Yiqing Qi, Liming Shen, Jilei Zhang et al. · Environmental Pollution · 2018 · 100 citations

Materials Science, Chemical Engineering, Engineering +3

Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity

Chao Zhong, Tianqi Liu, Sanhu Gou et al. · European Journal of Medicinal Chemistry · 2019 · 94 citations

Medicine, Vitro Biological Activity, Peptide Engineering +6

Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria

Ningyi Zhu, Chao Zhong, Tianqi Liu et al. · European Journal of Pharmaceutical Sciences · 2020 · 56 citations

Antimicrobial Susceptibility, Peptide Engineering, Antimicrobial Peptides +11